Senior Biotech Analyst – Seligman Investments

The biotech analyst position is a key member of the Healthcare Fund at Seligman Investments, part of Columbia Threadneedle Investments, an asset manager with over $1 trillion in assets under management and administration. This is a unique opportunity to join a growing fund with an entrepreneurial spirit integrated in a highly established and reputable investment firm/ platform. Our team has presence in New York, Menlo Park, Miami, and Boston.

Key Responsibilities

• Biotech sector coverage reporting to the Healthcare Portfolio Manager
• Develop investment theses by researching the industry and specific companies through medical and scientific due diligence, channel checks, earnings calls, company meetings, conferences and sell-side events
• Ability to accurately analyze complex medical literature, scientific data, statistical models and quickly distill key information that will impact investment decisions
• Communicate effectively research and new developments on a daily basis and track information about sector, companies, drug classes, regulatory and reimbursement decisions in a central repository
• Create valuation analyses on sector companies to arrive at price targets for existing holdings and price discrepancies on prospective holdings, based on fundamental drivers and a consistent valuation approach
• Develop trade recommendations rooted in carefully analyzed risk/ reward
• Deep understanding of financial statements and ability to create and maintain detailed financial models
• Strong work ethic, highest integrity, drive for results, entrepreneurial spirit, intellectual curiosity and honesty contributing to a positive culture and team environment

Required Qualifications

• 5 years in the biotechnology/ pharmaceutical sector either in clinical, scientific, financial services, or industry capacity
• 2 years of experience as a dedicated investment analyst covering biotech/ pharmaceuticals for an institutional asset manager

Preferred Qualifications

• Experience covering both biotech and pharmaceuticals across all key therapeutic areas for a hedge fund
• Experience with private investments and derivatives
• Advanced degree (eg, MS, PharmD, PhD, MD)

About Our Company
We’re a diversified financial services leader with more than $1 trillion in assets under management and administration as of 2022. Our team of 20,000 people in more than 20 countries, advise and manage assets and income of more than 2 million individual, small business and institutional clients. We are a longstanding leader in financial planning and advice, a global asset manager and an insurer. Our unwavering focus on our clients and strong financial foundation connects each of our unique businesses - Ameriprise Financial, Columbia Threadneedle Investments and RiverSource Insurance and Annuities. Here, we foster meaningful careers, invest in the future, and make a difference for clients, institutions and communities around the world.

The estimated base salary for this role is $175,000 - $250,000/year. We have a pay-for-performance compensation philosophy. Your initial total compensation may vary based on job-related knowledge, skills, experience, and geographical work location. In addition, most of our roles are eligible for variable pay in the form of bonus, commissions, and/or long-term incentives depending on the role. We also have a competitive and comprehensive benefits program that supports all aspects of your health and well-being, including but not limited to vacation time, sick time, 401(k), and health, dental and life insurances.Full timeExemptInvestment ManagementAMINV US Asset Management

Salary : $175,000 - $250,000